Identification and Validation of DNA Methylation Markers to Predict Lymph Node Metastasis of Esophageal Squamous Cell Carcinomas

被引：0
|
作者：
Ken Gyobu
Satoshi Yamashita
Yasunori Matsuda
Hiroyasu Igaki
Tohru Niwa
Daiji Oka
Ryoji Kushima
Harushi Osugi
Shigeru Lee
Shigefumi Suehiro
Toshikazu Ushijima
机构：
[1] National Cancer Center Research Institute,Carcinogenesis Division
[2] Graduate School of Medicine,Department of Gastrointestinal Surgery
[3] Osaka City University,Esophageal Surgery Division
[4] National Cancer Center Hospital,Pathology of Clinical Laboratory Division
[5] National Cancer Center Hospital,Department of Cardiovascular Surgery
[6] Graduate School of Medicine,undefined
[7] Osaka City University,undefined
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
Esophageal Squamous Cell Carcinoma; Methylation Status; Methylation Level; Metastatic Lymph Node; PAX6 Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1185 / 1194
页数：9
相关论文
共 50 条
  • [1] Identification and Validation of DNA Methylation Markers to Predict Lymph Node Metastasis of Esophageal Squamous Cell Carcinomas
    Gyobu, Ken
    Yamashita, Satoshi
    Matsuda, Yasunori
    Igaki, Hiroyasu
    Niwa, Tohru
    Oka, Daiji
    Kushima, Ryoji
    Osugi, Harushi
    Lee, Shigeru
    Suehiro, Shigefumi
    Ushijima, Toshikazu
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (04) : 1185 - 1194
  • [2] Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer
    Luo, Jianguo
    Chen, Shaojun
    Chen, Jingsen
    Zhou, Yige
    He, Fei
    Wang, Enli
    PLOS ONE, 2022, 17 (12):
  • [3] Genome-wide screening of DNA methylation markers to predict the presence of lymph node metastasis in esophageal squamous cell carcinoma
    Kozaki, Ken-ichi
    Nagata, Hiroaki
    Tanimoto, Kousuke
    Fujiwara, Naoto
    Imoto, Seiya
    Ichikawa, Daisuke
    Miyano, Satoru
    Kawano, Tatsuyuki
    Otsuji, Eigo
    Inazawa, Johji
    CANCER RESEARCH, 2014, 74 (19)
  • [4] The maximum tumor length and lymph node metastasis in esophageal squamous cell carcinomas
    Lv, Shuang
    Lv, Shuang
    Zhou, Fu You
    Yang, Hai Jun
    Li, Bei
    Liu, Li Na
    Xia, Yan Jie
    Qin, Yan Ru
    Fan, Rui Tai
    Xiao, Fan Kai
    Wang, Li Dong
    CANCER RESEARCH, 2017, 77
  • [5] Establishment and Validation of a Multi-Omics Nomogram to Predict Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma
    Li, Z.
    Li, B.
    MEDICAL PHYSICS, 2020, 47 (06) : E611 - E611
  • [6] Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma
    Nagata, Hiroaki
    Kozaki, Ken-Ichi
    Muramatsu, Tomoki
    Hiramoto, Hidekazu
    Tanimoto, Kousuke
    Fujiwara, Naoto
    Imoto, Seiya
    Ichikawa, Daisuke
    Otsuji, Eigo
    Miyano, Satoru
    Kawano, Tatsuyuki
    Inazawa, Johji
    ONCOTARGET, 2017, 8 (23) : 37740 - 37750
  • [7] A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma
    Roy, Roshni
    Kandimalla, Raju
    Sonohara, Fuminori
    Koike, Masahiko
    Kodera, Yasuhiro
    Takahashi, Naoki
    Yamada, Yasuhide
    Goel, Ajay
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (05) : 1160 - 1169
  • [8] A COMPREHENSIVE METHYLATION SIGNATURE IDENTIFIES LYMPH NODE METASTASIS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
    Roy, Roshni
    Kandimalla, Raju
    Sonohara, Fuminori
    Koike, Masahiko
    Kodera, Yasuhiro
    Takahashi, Naoki
    Yamada, Yasuhide
    Goel, Ajay
    GASTROENTEROLOGY, 2018, 154 (06) : S277 - S277
  • [9] Identification of novel biomarkers for lymph node metastasis of esophageal squamous cell carcinoma
    Luo, Xiaoqi
    Zhang, Shufan
    Yang, Manqiu
    Chen, Shaomu
    Huang, Moli
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 : 71 - 71
  • [10] A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma
    Duan, Xiaofeng
    Shang, Xiaobin
    Yue, Jie
    Ma, Zhao
    Chen, Chuangui
    Tang, Peng
    Jiang, Hongjing
    Yu, Zhentao
    BMC CANCER, 2021, 21 (01)
12345